Therapeutic agent for sleep apnea

PCT No. PCT/JP90/00947 Sec. 371 Date Mar. 8, 1993 Sec. 102(e) Date Mar. 8, 1993 PCT Filed Jul. 25, 1990 PCT Pub. No. WO92/01448 PCT Pub. Date Aug. 6, 1992.Administration of ubidecarenone is effective for the therapy of sleep apnea. It is given at a dose of 1-3,000 mg per day in adults. It is especia...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MIYAO, KOUHEI, NISHIMURA, TATEO, SETSUKO
Format:	Patent
Sprache:	eng
Schlagworte:	ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PCT No. PCT/JP90/00947 Sec. 371 Date Mar. 8, 1993 Sec. 102(e) Date Mar. 8, 1993 PCT Filed Jul. 25, 1990 PCT Pub. No. WO92/01448 PCT Pub. Date Aug. 6, 1992.Administration of ubidecarenone is effective for the therapy of sleep apnea. It is given at a dose of 1-3,000 mg per day in adults. It is especially effective to administer ubidecarenone to the patient before bed at a dose of 2-50 mg.